Company filings and market news from across Sri Lanka's stock market.
Asia Frontier Capital has increased its weight on Sri Lanka equities to 14% from about 5% two years ago. The fund cites improving macro fundamentals, political stability and pickup in tourism and corporate earnings, and lists holdings including JKH, Commercial Bank, HNB, Hemas, Sunshine, Dipped Products and Melstacorp.
ASPI fell 0.4% and the S&P SL20 fell 0.7% as Colombo stocks extended losses amid heightened Israel‑Iran tensions. Turnover was Rs.3.15bn; top negative contributors included HNB, COMB, LOLC, HAYL and CTC, while CDB, Hemas, LVL Energy Fund and Lanka IOC saw notable buying/turnover.
The Sri Lanka Institute of Directors will hold a Family Business Forum on 17 June 2025 at Cinnamon Grand Colombo, partnered by the SEC, CSE and KPMG to discuss succession planning, governance and pathways to public listing. Speakers include executives from Hemas, Janashakthi, NDB Capital and Sampath Bank, with a keynote by KPMG's Daniel Trimarchi.
ACCA Sri Lanka held its AGM on 5 June, reaffirming Chaaminda Kumarasiri as Chairman and appointing a Member Network Panel that includes Hemas Holdings Group CFO Moiz Rehmanjee and Hayleys finance director Sashi Jayakody. ACCA outlined its 2025/26 strategy and highlighted initiatives such as an AI-powered chatbot and sustainability reporting awards.
Colombo market sustained an all-time high as the ASPI closed at 17,500.24, up 105.79 points (+0.61%) with turnover Rs.2.85bn and net foreign outflow of Rs.19.3m. Banking-led activity and retail buying drove gains, with Hayleys Fabric, Ceylinco, Ceylon Cold Stores, HNB and Ceylon Tobacco among top drivers.
Colombo market stayed at an all-time high as the ASPI rose 82 points (0.47%) on turnover of Rs.5.6bn, led by heavy activity in John Keells, Hemas, Browns Investments, People’s Leasing and Lanka Milk Foods; foreign investors were net buyers of Rs.41.4mn and capital goods and diversified financials led turnover.
ASPI rose 81.89 points to a record 17,434.94, extending its rally to a 12th straight session led by John Keells, Sampath Bank, Hatton National Bank, Lion Brewery and Dipped Products. Market turnover was Rs.5.59bn and the S&P SL20 gained 34.13 pts to 5,193.79.
ASPI rose 138 points (0.8%) to 17,353 as the CSE extended its rally on turnover of Rs.7.37bn, led by heavy trading in CDB and CFIN; notable price gains were seen in CDB, CFIN, CTC, HHL, CIC and SUN, while SPEN topped net foreign buying and PKME topped net foreign selling.
Colombo Stock Exchange ASPI rose 0.81% to 17,353.05 on Wednesday. Top contributors included Ceylon Tobacco (+108.50 to 1,488.75), Lion Brewery (+120.25 to 1,420.50), Central Finance (+12.25 to 234.50), Hemas (+1.20 to 29.70) and Cargills (+22.25 to 569.75).
Colombo Stock Exchange hit a record as the ASPI closed at 17,353.05 (+138.66 pts, 0.81%) on June 4, 2025. The S&P SL20 rose to 5,159.66 (+0.55%) with turnover Rs.7.37bn, led by gains in CTC, CFIN, HHL, LION and CARG.
Colombo market rose with ASPI +0.6% and S&P SL20 +0.9% on turnover of Rs.6.4bn, led by Sampath Bank, LOLC, Hemas and Sierra Cables; foreigners were net sellers (Rs.218m outflow). Several firms made gains and interim dividends were announced (RIL, UML).
Colombo market extended gains as the ASPI rose 0.33% and the S&P SL20 0.19% on turnover of Rs.4.3 billion, while foreigners were net sellers of Rs.162.7 million. Hemas, Commercial Bank, Aitken Spence, Sampath and Digital Mobility were top contributors; John Keells and Hatton National Bank fell.
Sri Lanka's ASPI rose 0.33% (55.24 pts) to 16,712 on Wednesday with turnover of 4.2 billion rupees; top contributors were Hemas, Commercial Bank, Aitken Spence, Dialog Axiata and Sampath Bank, while John Keells weighed on the index after a 71% profit decline.
Colombo market opened subdued with the ASPI up 1.78 points and turnover rising to Rs. 3.7bn; foreigners were net buyers of Rs. 70.1m. Key contributors included CCS, HHL, HAYL, DIAL and BIL, with strong activity in Food, Beverage & Tobacco.
The Colombo Stock Exchange ended the week with the ASPI up 0.6% and net foreign inflows of Rs.155.9 million, with weekly turnover averaging Rs.2.97 billion; notable contributors included HHL, COOP, SUN, CTHR and BUKI.
CBSL cut the OPR by 25bps to 7.75%, boosting the Colombo market (ASPI +0.7%, S&P SL20 +0.54%) on higher turnover; key contributors were CARG, MELS, JKH, DIAL and HHL, with strong banking interest and Rs.313.4m foreign net inflows.
Hemas Holdings PLC reported FY25 cumulative earnings of Rs. 8.1 billion, up 31.9% year-on-year, while group revenue declined marginally and Fitch reaffirmed its 'AAA (lka)' rating. Healthcare and Mobility drove profit growth; the group declared a final dividend of 70 cents and a 5-for-1 share sub-division.
Central Bank cut rates by 25 basis points, lifting the Colombo Stock Exchange 0.19% as the ASPI closed 31.49 points higher at 16,504.86. Hemas, Co-operative Insurance, Sunshine, C T Holdings, Bukit Darah and Haycarb were among gainers while Teejay Lanka and Dipped Products fell.
Dividend · Rs 0.70 · XD Jun 26, 2025
Final dividend of LKR 0.7/share; XD 2025-06-26; record 2025-06-26; payable 2025-07-16; FY ended 31.03.2025
The central bank cut its policy rate by 25 bps to 7.75%, and Sri Lanka stocks closed higher—ASPI +0.72% and S&P SL20 +0.54%. Top contributors included Cargills, Melstacorp, John Keells, Dialog Axiata and Hemas.
Hemas Holdings PLC appointed Ashish Chandra as Group CEO, effective 1 July 2025. Chandra, a 27-year industry veteran with telecom and digital transformation experience, will lead growth across larger emerging markets, expansion into adjacencies and technology-led transformation.
Hemas Holdings PLC appointed Ashish Chandra as Group Chief Executive Officer, effective 1 July 2025. He joins from Airtel Sri Lanka and will focus on accelerating growth in emerging markets, expanding adjacencies and driving technology-led transformation.
Colombo market ended the session marginally down with the ASPI falling 10 points to 15,916 while both ASPI and S&P SL20 gained 0.4% for the week; turnover was about Rs.1.5–1.54 billion and Materials led activity. Ceylon Grain Elevators (GRAN) rose 6.06% and HNB gained, while HHL, TJL, SPEN and RCL pressured the index; ACME closed flat.
Sri Lanka stocks closed marginally weaker as the ASPI fell 0.06% to 15,916.17 amid lower turnover and investor caution over IMF talks, US tariff discussions and GSP+ uncertainty. HNB reported March-quarter profit up 48% to LKR 10.6 billion, while several exporters and tourism-linked stocks fell.
Fitch affirmed Hemas Holdings PLC's National Long-Term Rating at 'AAA (lka)' with a Stable Outlook, citing defensive cash flows and leading positions in pharmaceuticals and HPC; Fitch expects capex to rise to ~Rs.7bn p.a. in FY26–FY27 and forecasts EBITDA net leverage below 1.0x.
Colombo bourse rose as the ASPI gained 69 points (0.44%) to close at 15,811 on turnover of Rs. 2.79bn, while foreigners were net sellers (net outflow Rs. 101.4m). John Keells, Hemas, Vallibel Finance and Commercial Bank were among top contributors, with capital goods leading turnover and diversified financials and food/beverage active.
Fitch affirmed Hemas Holdings PLC's national long-term rating at 'AAA(lka)' with a Stable Outlook. Fitch cited the group's defensive operating cash flows (healthcare and consumer brands ~90% of EBIT) and noted planned capex rising to around LKR7.0 billion annually in FY26–FY27.
Colombo Bourse closed the week higher, with the ASPI up ~2% and finishing at 15,742 after a 126-point gain on Friday. Market gains were led by LOLC, RCL, NDB, SUN and MELS, with Friday turnover at Rs.2.4bn (Capital Goods, Food & Beverage and Diversified Financials leading) while foreigners were net sellers (Rs.103.6m).
The ASPI gained 72 points (+0.5%) to 15,616 as the Colombo market bounced back, led by the capital goods sector. Turnover was about Rs.1.5 billion with net foreign inflows of Rs.35.2m; notable movers included Hemas, John Keells, Browns, Alumex and DFCC.
Hemas Holdings (HHL.N0000) has appointed Dr. Mahesha Ranasoma as Managing Director of Hemas Pharmaceuticals and Hemas Surgicals & Diagnostics. He brings over 25 years of cross-sector leadership experience, including roles at Dipped Products PLC and Shell.